: Lexeo Therapeutics files for IPO
Lexeo Therapeutics filed for an IPO on Friday. The company develops genetic medicines, with candidates for treatment of Friedreich’s ataxia and Alzheimer’s currently being evaluated....
: Biogen gets FDA approval for biotech treatment similar to Roche’s Actemra
Biogen Inc. BIIB said late Friday the Food and Drug Administration approved its biosimilar version of Roche CH:ROG‘s arthritis treatment Actemra. Biogen said its treatment...
JetBlue raises flight attendant pay, union agrees to support merger with Spirit
JetBlue is raising flight attendant pay by 5% while union agreed to support the airline's acquisition of budget carrier Spirit.
Market Extra: September’s U.S. stock-market rout left just 1 winner as defensive sectors failed to provide shelter
Traditional defensive sectors didn't fare well in September's stock-market drop. Here's why.
: Barstool Sports’ Dave Portnoy buys record-setting $42 million house in Nantucket
Portnoy's new home will reportedly have an underground tunnel.
: Government shutdown may delay Social Security’s COLA release
The COLA announcement is expected Oct. 12, but could be pushed back if a shutdown persists
: Flash flooding in New York City halts multiple train lines and cancels hundreds of flights
Much of the city's subway service has been suspended and more than 300 flights have been canceled.
: Oil futures end lower for the session, higher for the month and quarter
Oil futures declined on Friday, but U.S. prices notched a gain of nearly 9% for the month. “Oil was solidly on its path to $100,...
Blue Apron to be acquired by Wonder Group for $103 million, capping tumultuous post-IPO ride
Blue Apron has in recent months transitioned to become a more asset-light business, selling its operational infrastructure and laying off staff.